|
Market Closed -
Toronto S.E.
15:59:13 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 12.45 CAD | -0.64% |
|
+2.81% | +57.20% |
Company Valuation: Satellos Bioscience Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6.794 | 36.73 | 95.65 | 89.3 | 190.9 | - | - |
| Change | - | 440.53% | 160.46% | -6.65% | 113.81% | - | - |
| Enterprise Value (EV) 1 | 6.794 | 36.73 | 46.68 | 89.3 | 89.32 | 71.92 | 3.721 |
| Change | - | 440.53% | 27.11% | 91.29% | 0.03% | -19.48% | -94.83% |
| P/E | - | - | -3.32x | -3.36x | -4.22x | -5.65x | -5.7x |
| PBR | - | - | - | - | 5.28x | 4.15x | - |
| PEG | - | - | - | 0.2x | -0.2x | 0.2x | 6.34x |
| Capitalization / Revenue | - | - | - | - | - | - | 26.5x |
| EV / Revenue | - | - | - | - | - | - | 0.52x |
| EV / EBITDA | - | - | - | -3.38x | -3.57x | -2.59x | -0.13x |
| EV / EBIT | -1.08x | -3.23x | -2.4x | -3.37x | -1.94x | -1.31x | -0.06x |
| EV / FCF | - | - | -2.67x | - | -2.12x | -1.9x | -0.07x |
| FCF Yield | - | - | -37.5% | - | -47.1% | -52.6% | -1,396% |
| Dividend per Share 3 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 3 | - | - | -3 | -2.354 | -2.949 | -2.205 | -2.186 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | 7.217 |
| EBITDA 1 | - | - | - | -26.46 | -25 | -27.75 | -28 |
| EBIT 1 | -6.268 | -11.38 | -19.45 | -26.46 | -46.12 | -54.73 | -61.77 |
| Net income 1 | -8.368 | -11.69 | -19.65 | -24.87 | -49.06 | -62.88 | -76.74 |
| Net Debt 1 | - | - | -48.97 | - | -101.6 | -119 | -187.2 |
| Reference price 3 | 2.64 | 5.16 | 9.96 | 7.92 | 12.45 | 12.45 | 12.45 |
| Nbr of stocks (in thousands) | 3,483 | 9,399 | 13,818 | 15,459 | 21,216 | - | - |
| Announcement Date | 3/30/23 | 3/27/24 | 3/26/25 | 3/27/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.22x | - | -3.57x | - | 191M | |
| 20.25x | 7.04x | 14.2x | 1.45% | 67.98B | |
| 36.9x | 9.64x | 29.44x | 0.04% | 64.94B | |
| -77.3x | 14.92x | -71.95x | -.--% | 27.58B | |
| 29.69x | 6.35x | 16.48x | -.--% | 25.74B | |
| -15.85x | 6.12x | -7.7x | -.--% | 26.06B | |
| 27.41x | 5.13x | 17.06x | -.--% | 20.09B | |
| 49.41x | 18.23x | 36.98x | 0.31% | 17.16B | |
| 1289.22x | 37.23x | 812.54x | -.--% | 14.92B | |
| 18.23x | 5.44x | 12.69x | -.--% | 14.62B | |
| Average | 137.37x | 12.23x | 85.62x | 0.2% | 27.93B | |
| Weighted average by Cap. | 81.96x | 10.35x | 51.56x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MSCL Stock
- Valuation Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
